Diagnostic pitfalls in vitamin B6‐dependent epilepsy caused by mutations in the PLPBP gene
JIMD Reports · 2019-11 · 50 (1) · 1-8
DOI: 10.1002/jmd2.12063 ↗Kurz gefasst
Fallbericht in der Zeitschrift JIMD Reports, online erschienen am 30.09.2019. Verfasst von Kristian Vestergaard Jensen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology Copenhagen University Hospital Copenhagen Denmark. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vitamin B6‐responsive epilepsies are a group of genetic disorders including ALDH7A1 deficiency, PNPO deficiency, and others, usually causing neonatal onset seizures resistant to treatment with common antiepileptic drugs. Recently, biallelic mutations in PLPBP were shown to be a novel cause of vitamin B6‐dependent epilepsy with a variable phenotype. The different vitamin B6‐responsive epilepsies can be detected and distinguished by their respective biomarkers and genetic analysis. Unfortunately, metabolic biomarkers for early detection and prognosis of PLPBP deficiency are currently still lacking. Here, we present data from two further patients with vitamin B6‐dependent seizures caused by variants in PLPBP , including a novel missense variant, and compare their genotype and phenotypic presentation to previously described cases. Hyperglycinemia and hyperlactatemia are the most consistently observed biochemical abnormalities in pyridoxal phosphate homeostasis protein (PLPHP) deficient patients and were present in both patients in this report within the first days of life. Lactic acidemia, the neuroradiological, and clinical presentation led to misdiagnosis of a mitochondrial encephalopathy in two previously published cases with an early fatal course. Similarly, on the background of glycine elevation in plasma, glycine encephalopathy was wrongly adopted as diagnosis for a patient in our report. In this regard, lactic acidemia as well as hyperglycinemia appear to be diagnostic pitfalls in patients with vitamin B6‐responsive epilepsies, including PLPHP deficiency. Synopsis In vitamin B6‐responsive epilepsies, including PLPHP deficiency, there are several diagnostic pitfalls, including lactic acidemia as well as hyperglycinemia, highlighting the importance of a pyridoxine trial, and genetic testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology Copenhagen University Hospital Copenhagen Denmark.
- Department of Paediatrics Ryhov County Hospital Jönköping Sweden.
- Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden.
- Neuropaediatric Unit Karolinska University Hospital Stockholm Sweden.
- Centre for Inherited Metabolic Diseases Karolinska University Hospital Stockholm Sweden.
- Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden.
ORCID-Profile: Sabine Grønborg
Zitieren
APA
Jensen, K. V., Frid, M., Stödberg, T., Barbaro, M., Wedell, A., Christensen, M., Bak, M., Ek, J., Madsen, C. G., Darin, N., & Grønborg, S. (2019). Diagnostic pitfalls in vitamin B6‐dependent epilepsy caused by mutations in the PLPBP gene. JIMD Reports, 50(1), 1-8. https://doi.org/10.1002/jmd2.12063
Vancouver
Jensen KV, Frid M, Stödberg T, Barbaro M, Wedell A, Christensen M, et al. Diagnostic pitfalls in vitamin B6‐dependent epilepsy caused by mutations in the PLPBP gene. JIMD Reports. 2019;50(1):1-8. doi:10.1002/jmd2.12063
BibTeX
@article{Jensen2019,
author = {Jensen, Kristian Vestergaard and Frid, Maria and Stödberg, Tommy and Barbaro, Michela and Wedell, Anna and Christensen, Mette and Bak, Mads and Ek, Jakob and Madsen, Camilla Gøbel and Darin, Niklas and Grønborg, Sabine},
title = {Diagnostic pitfalls in vitamin B6‐dependent epilepsy caused by mutations in the PLPBP gene},
journal = {JIMD Reports},
year = {2019},
volume = {50},
number = {1},
pages = {1--8},
doi = {10.1002/jmd2.12063}
}
EUVIMED